Currently, there are 411.96M common shares owned by the public and among those 303.29M shares have been available to trade.
The company’s stock has a 5-day price change of 37.80% and -13.25% over the past three months. AGL shares are trading 51.58% year to date (YTD), with the 12-month market performance down to -63.91% lower. It has a 12-month low price of $1.50 and touched a high of $8.20 over the same period. AGL has an average intraday trading volume of 4.06 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 38.69%, 36.20%, and -33.93% respectively.
Institutional ownership of Agilon Health Inc (NYSE: AGL) shares accounts for 80.58% of the company’s 411.96M shares outstanding.
It has a market capitalization of $1.19B and a beta (3y monthly) value of 0.47. The earnings-per-share (ttm) stands at -$0.82. Price movements for the stock have been influenced by the stock’s volatility, which stands at 12.86% over the week and 9.55% over the month.
Earnings per share for the fiscal year are expected to decrease by -15.75%, and 38.05% over the next financial year.
Looking at the support for the AGL, a number of firms have released research notes about the stock. Citigroup stated their Neutral rating for the stock in a research note on January 10, 2025, with the firm’s price target at $1.75-$2.25. Macquarie was of a view on December 16, 2024 that the stock is Neutral, while Bernstein gave the stock Mkt Perform rating on December 11, 2024, issuing a price target of $2.50. JMP Securities on their part issued Mkt Perform rating on November 11, 2024.
